KFDA to face criticism over efficacy fabrication of generic drugs

The Korea Food and Drug Administration (KFDA) will come under fire from governing and opposition party lawmakers of the National Assembly's Health and Welfare Committee on September 7 for the way it responded to manipulation of test results of generic drugs' efficacy.

At the special committee, the legislators will also criticize the administration's lukewarm, delayed response to the controve...